Suppr超能文献

该属中两种食用药用植物的药物系统发育关系。

The pharmacophylogenetic relationships of two edible medicinal plants in the genus .

作者信息

Cui Zhanhu, Li Siqi, Chang Jiayin, Zang Erhuan, Liu Qian, Zhou Baochang, Li Chao, Li Mengzhi, Huang Xianzhang, Zhang Zhongyi, Li Minhui

机构信息

College of Agriculture, Fujian Agriculture and Forestry University, Fuzhou, China.

The First People's Hospital of Nanyang Affiliated to Henan University, Nanyang, China.

出版信息

Front Plant Sci. 2022 Aug 18;13:949743. doi: 10.3389/fpls.2022.949743. eCollection 2022.

Abstract

and are edible medicinal plants belonging to the genus in the Asteraceae. There are many similarities in their morphology, traditional curative effect, and modern pharmacological treatment. In this study, we built distribution maps of and in China and a phylogenetic tree of common medicinal plants in Asteraceae. Then, we verified the chemical composition changes of and via their metabolome. Traditional efficacy and modern pharmacological action were verified by network pharmacology and using RAW264.7 cells. The results showed that and are widely distributed in China, and they shared pharmaphylogeny, which provides theoretical support for the mixed use of and in most regions of China. Furthermore, there were both similarities and differences in volatile oil and flavonoid composition between and . The network pharmacology results showed that and had 23 common active compounds and that both had pharmacological effects on chronic gastritis (CG). Molecular docking analyses showed that quercetin, luteolin, and kaempferol have strong binding affinities with the target proteins JUN, TP53, AKT1, MAPK3, TNF, MAPK, and IL6. The cell experiment results further demonstrated that and treat CG the NOD-like receptor pathway. Based on the theory of pharmaphylogeny, this study explored the pharmaphylogeny between and from various perspectives to provide a basis for the substitution of and .

摘要

[植物名称1]和[植物名称2]是菊科[属名]属的可食用药用植物。它们在形态、传统疗效和现代药理治疗方面有许多相似之处。在本研究中,我们绘制了[植物名称1]和[植物名称2]在中国的分布图以及菊科常见药用植物的系统发育树。然后,我们通过代谢组学验证了[植物名称1]和[植物名称2]的化学成分变化。通过网络药理学和使用RAW264.7细胞验证了传统疗效和现代药理作用。结果表明,[植物名称1]和[植物名称2]在中国分布广泛,它们具有药用系统发育关系,这为中国大部分地区[植物名称1]和[植物名称2]的混合使用提供了理论支持。此外,[植物名称1]和[植物名称2]在挥发油和黄酮类成分上既有相似之处也有差异。网络药理学结果表明,[植物名称1]和[植物名称2]有23种共同的活性化合物,且二者对慢性胃炎(CG)均有药理作用。分子对接分析表明,槲皮素、木犀草素和山奈酚与靶蛋白JUN、TP53、AKT1、MAPK3、TNF、MAPK和IL6具有很强的结合亲和力。细胞实验结果进一步证明,[植物名称1]和[植物名称2]通过NOD样受体途径治疗CG。基于药用系统发育理论,本研究从多个角度探索了[植物名称1]和[植物名称2]之间的药用系统发育关系,为[植物名称1]和[植物名称2]的替代提供依据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bf5/9436419/630ed01ea7a5/fpls-13-949743-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验